Leeson-Payne, A
Nearly 1,000 plaintiffs claim the drugs caused pancreatic cancer and pancreatitis. Drug Watch 3/28/18 Diabetes drug lawsuits filed against the manufacturers of Byetta, Januvia and Victoza are moving forward once again, as a federal court housing hundreds of pancreatic cancer claims recently adopted a new schedule that could allow bellwether trials to begin in January 2020
Centre for Vascular Research School of Medical Sciences (Pathology) and Bosch Institute Sydney Medical School The University of Sydney Sydney, New South Wales, Australia Copyright 2003-2026 Linus Pauling Institute Figure Alternative Text Figure 1
Beyond individual trials, a 2025 meta-analysis covering over 140,000 participants found tirzepatide yields a mean 4.23% greater weight loss than semaglutide (95% CI: 3.22 5.25
It's more evidence for what I write about in "Lies I Taught in Medical School": the metabolic dysfunction driving obesity is the same dysfunction driving depression, anxiety, and addiction
To ensure absolute transparency and scientific validity, we have established a distinct testing framework tailored to each of our peptide preparations